Skip to content

CONGRESS PHARMA

Active Private limited companyfounded 2020active for 6 yearsTervurenlaan 295, 1150 Woluwe-Saint-PierreKBO/BCE: BE 0743.735.919

Board

1 director, no change since 2022
Director
since 28-01-2022 term until 15-06-2027
also on the board of 1 other company
listed in the 2025 annual accounts, filed on 16-07-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Article 15. Pouvoirs de l’organe d’administration S’il n’y a qu’un seul administrateur, la totalité des pouvoirs d’administration lui est…”
deed of 19-02-2020

Office holders in the KBO →

Mandates through the years

2 names, the dashed line is today

Director

Director (not named in the articles)
BoardEarlierRest of the termmandate already running before its first mention
Mandates as a list
    • Director, since before 31-12-2020
    • Director (not named in the articles), from 17-02-2020 to 08-03-2022

Control

Founder
This company
CONGRESS PHARMA
Equity €10,393
Loss €301 in 2025

Capital

Contribution
€1
Shares
10
Contribution per share
€0.10
Equity per share
€1,039 in 2025
Source
deed of 19-02-2020

Articles of association

deed of 19-02-2020 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 1 director
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Third Tuesday of June at 17:00

Shareholders

At incorporation deed of 19-02-2020 ↗
  • 10 shares (100%) · in cash

Next steps